B Cell Lymphoma - Articles

Sort by: Newest Most Comments Relevance

Ugly Cell: Diffuse Large B-Cell Lymphoma in the Brain by Dr. Brian M. Medical Doctor

Posted Mon 26 Jan 2009 3:49pm A 69-year-old woman presented with a brain mass that was thought to be a primary brain tumor. Instead, our diagnosis turned out to be Diffuse Large B-Cell Lymphoma, Anaplastic Type. This is not a lymphoma that is restricted to the central nervous system; but thus far in this patient the malignancy has only shown up in the brain. A representative Read on »

Mediastinal large B-cell lymphoma associated with systemic sclerosis by Jan Posted Mon 21 Dec 2009 10:17pm Malignant lymphoma (ML) is frequently associated with several forms of collagen diseases such as Sjören syndrome, systemic lupus erythematodes, and rheumatoid arthritis. However, the occurrence of ML in systemic sclerosis (SSc) patients has rarely been reported. Here we report an SSc patient who developed mediastinal (thymic) large B-cell lymphoma Read on »

Revlimid for refractory relapsed B-cell lymphoma by Mark Levin Posted Wed 24 Jun 2009 7:01pm response to single agent lenalidomide was 28%, with 6 responses in the diffuse large B-cell lymphoma group (21%) and 5 in the mantle cell lymphoma group (38%). Ten patients had... of lenalidomide oral monotherapy in patients with relapsed or refractory diffuse large-B-cell lymphoma: Results of an international study *NHL-003). Blood. 2008;112:103, abstract 268. M Read on »

Revlimid for mantle cell lymphoma by Mark Levin Posted Thu 15 Jul 2010 3:34am Stub There is phase II support for Revlimd for mantle lymphoma. The NCCN Drugs & Biologics Compendium recognizes the use of lenalidomide for Mantle Cell lymphoma. Habermann TM, Lossos IS, Justice G, et al. Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma. British Journal Read on »

Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants: Preliminary FDA Findings and Analyses by FDA Posted Wed 26 Jan 2011 12:00am to the implant. The report pointed out that in the general population, breast lymphomas are a rare disease entity and that most are of B-cell origin. In contrast, nearly every case... lymphomas reported in patients without breast implants are of the B-cell phenotype . In contrast, ALCL is a T-cell lymphoma, suggesting the observation may be more than chance . 2 Read on »

FDA Grants Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID®, Targeting Mantle Cell Lymphoma by Health: Hearsay & Headlines Posted Tue 27 Jul 2010 6:11am ®, Biovest’s personalized cancer vaccine, for a second lymphoma indication: mantle cell lymphoma. Mantle cell lymphoma is an aggressive and lethal B-cell blood cancer for which there is no current consensus standard-of-care. Mantle cell lymphoma is the newest disease for which Biovest has announced its intent to pursue regulatory approval for and Orphan Drug Read on »

FDA Approves First Drug for Treatment of Peripheral T-cell Lymphoma by Health: Hearsay & Headlines Posted Tue 13 Oct 2009 10:04pm The U.S. Food and Drug Administration has approved Folotyn (pralatrexate), the first treatment for a form of cancer known as Peripheral T-cell Lymphoma (PTCL), an often... system. There are many types of lymphoma: one type is called Hodgkin's disease, and the rest are called non-Hodgkin's lymphomas. PTCL involves a type of white blood cell called Read on »

Romidepsin for T-Cell Lymphoma by Cancer.gov Posted Tue 22 Feb 2011 11:14pm ... Read on »

FDA Medical Device Safety Communication: Reports of Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants by FDA Posted Wed 26 Jan 2011 12:00am large cell lymphoma (ALCL). Although ALCL is extremely rare, the FDA believes that women with breast implants may have a very small but increased risk of developing this disease... and discussion of these cases can be found in the document Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants: Preliminary FDA Findings and Analyses . ALCL is Lymphoma Read on »

Information on Anaplastic Large Cell Lymphoma (ALCL) and Women with Breast Implants by FDA Posted Wed 26 Jan 2011 12:00am The FDA has identified a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare.... Related Information FDA Medical Device Safety Communication: Reports of Anaplastic Large Cell Lymphoma (ALCL) in Women with Breast Implants Read on »